Treatment of lipid disorders in non-insulin-dependent diabetes mellitus

被引:7
作者
Gylling, H [1 ]
Miettinen, TA [1 ]
机构
[1] Univ Helsinki, Dept Med, Div Internal Med, FIN-00290 Helsinki, Finland
关键词
D O I
10.1097/00041433-199712000-00004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The basis for treatment of lipid disorders in patients with non-insulin-dependent diabetes mellitus is weight reduction by diet and exercise, and additional control of glycaemic condition with oral antidiabetics, alone or in combination with insulin. Hypercholesterolaemic, mildly hypertriglyceridaemic non-insulin-dependent diabetes mellitus patients respond to cholesterol malabsorption caused by dietary sitostanol ester margarine, while long-term statin treatment of respective coronary patients significantly lowers the recurrence of coronary events, in addition to improving the lipid disorder. However, no information is available concerning the preventive effect of long-term improvement of lipid disorders in non-insulin-dependent diabetes mellitus patients without coronary heart disease, or in patients with the `classical' type of diabetic lipid disorder, that is, hypertriglyceridaemia with low HDL and normal - low LDL-cholesterol levels. In this group of patients, beneficial lipid effects can be obtained (although perhaps not normalization) with fibrates alone or, especially, in combination with current statins.
引用
收藏
页码:342 / 347
页数:6
相关论文
共 74 条
[1]  
ANDERSEN E, 1986, DIABETES METAB, V12, P261
[2]   Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with noninsulin-dependent diabetes mellitus [J].
Andersson, B ;
Mattsson, LA ;
Hahn, L ;
Marin, P ;
Lapidus, L ;
Holm, G ;
Bengtsson, BA ;
Bjorntorp, P .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (02) :638-643
[3]   Impaired glucose tolerance is normalized by treatment with the thiazolidinedione troglitazone [J].
Antonucci, T ;
Whitcomb, R ;
McLain, R ;
Lockwood, D .
DIABETES CARE, 1997, 20 (02) :188-193
[4]   IMPROVED DIABETIC CONTROL AND HYPOCHOLESTEROLEMIC EFFECT INDUCED BY LONG-TERM DIETARY SUPPLEMENTATION WITH GUAR GUM IN TYPE-2 (INSULIN-INDEPENDENT) DIABETES [J].
ARO, A ;
UUSITUPA, M ;
VOUTILAINEN, E ;
HERSIO, K ;
KORHONEN, T ;
SIITONEN, O .
DIABETOLOGIA, 1981, 21 (01) :29-33
[5]   Effects of multiple daily insulin injections and intraperitoneal insulin therapy on cholesteryl ester transfer and lipoprotein lipase activities in NIDDM [J].
Bagdade, JD ;
Kelley, DE ;
Henry, RR ;
Eckel, RH ;
Ritter, MC .
DIABETES, 1997, 46 (03) :414-420
[6]   Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia [J].
BakkerArkema, RG ;
Davidson, MH ;
Goldstein, RJ ;
Davignon, J ;
Isaacsohn, JL ;
Weiss, SR ;
Keilson, LM ;
Brown, WV ;
Miller, VT ;
Shurzinske, LJ ;
Black, DM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (02) :128-133
[7]   A MULTINATIONAL STUDY OF THE EFFECTS OF LOW-DOSE PRAVASTATIN IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS AND HYPERCHOLESTEROLEMIA [J].
BEHOUNEK, BD ;
MCGOVERN, ME ;
KASSLERTAUB, KB ;
MARKOWITZ, JS ;
BERGMAN, M ;
BEDARD, J ;
LEITER, L ;
OLEARY, TJ ;
TAN, MH ;
TILDESLEY, HD ;
BERTHEZENE ;
KREMPF ;
MOINADE ;
PASSA ;
WEMEAU ;
BIESENBACH ;
DAMMANN ;
ERHARD ;
HEBBELN ;
HUTH ;
MAHLA ;
MARTENS ;
PATSCH ;
SCHNEIDER ;
SCHOLTEN ;
TEUBER ;
WEISWEILER ;
BARON, H ;
KLEINMAN ;
SEGAL, P ;
YESHURON, D ;
AWUNORRENNER, C ;
CONALGEN, JC ;
FEEK, CM .
CLINICAL CARDIOLOGY, 1994, 17 (10) :558-562
[8]  
Berkowitz R, 1996, DIABETES, V45, P1572
[9]  
Betteridge DJ, 1997, DIABETES METAB REV, V13, P99, DOI 10.1002/(SICI)1099-0895(199706)13:2&lt
[10]  
99::AID-DMR183&gt